Genetic study predicts optimal use of 'Tacrolimus' for kidney transplant patients
The dose prediction study was focused on the immunosuppressant drug tacrolimus, which is given to a kidney, heart or liver transplant patient to lower the body's immunity and thereby considerably reducing the chances of organ rejection.